[B! å¿½é‚£è³¢å¿—] neko2boã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

neko2bo id:neko2bo

å¿½é‚£è³¢å¿—ã«é–¢ã™ã‚‹neko2boã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (7)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

ç—‡çŠ¶ã€äºˆé˜²ã€çµŒéŽã¨æ²»ç™‚â€¦ã€€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã¨ã¯ï¼Ÿã€€ç¾æ™‚ç‚¹ã§åˆ†ã‹ã£ã¦ã„ã‚‹ã“ã¨ï¼ˆ2021å¹´5æœˆï¼‰ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
æµè¡Œã‹ã‚‰1å¹´ä»¥ä¸ŠãŒçµŒéŽã—ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã«ã¤ã„ã¦æ§˜ã€…ãªã“ã¨ãŒåˆ†ã‹ã£ã¦ãã¾ã—ãŸã€‚ æµè¡ŒçŠ¶æ³ã€ç—‡çŠ¶ã€æ²»ç™‚ã€äºˆé˜²ãªã©ç¾æ™‚ç‚¹ã§åˆ†ã‹ã£ã¦ã„ã‚‹ã“ã¨ã«ã¤ã„ã¦ã¾ã¨ã‚ã¦ã„ã¾ã™ï¼ˆè¨˜äº‹ã®å†…å®¹ã¯2021å¹´5æœˆ29æ—¥æ™‚ç‚¹ã§ã®æƒ…å ±ã§ã™ï¼‰ã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¨ã¯ï¼Ÿæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ§‹é€ ï¼ˆCDC Image Libraryã‚ˆã‚Šï¼‰ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ï¼ˆSARSã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹2ï¼‰ã¯ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ï¼ˆCOVID-19ï¼‰ã®åŽŸå› ã‚¦ã‚¤ãƒ«ã‚¹ã§ã€RNAã‚¦ã‚¤ãƒ«ã‚¹ã§ã‚ã‚‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®ä»²é–“ã§ã™ã€‚ ã‚¦ã‚¤ãƒ«ã‚¹ç²’åã®è¡¨é¢ã«ã‚¹ãƒ‘ã‚¤ã‚¯è›‹ç™½ã¨å‘¼ã°ã‚Œã‚‹çªèµ·ãŒã‚ã‚Šã€ã“ã‚ŒãŒçŽ‹å† ã®ã‚ˆã†ã«è¦‹ãˆã‚‹ã“ã¨ã‹ã‚‰ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¨åä»˜ã‘ã‚‰ã‚Œã¾ã—ãŸã€‚ SARSã€MERSã€æ–°åž‹ã‚³ãƒãƒŠã®æ¯”è¼ƒï¼ˆç†è€…ä½œæˆï¼‰ ã“ã‚Œã¾ã§ã«ãƒ’ãƒˆã«æ„ŸæŸ“ã™ã‚‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¯4ç¨®é¡žçŸ¥ã‚‰ã‚Œã¦ãŠã‚Šã€ã‹ãœã®åŽŸå› ã®10ã€œ30ï¼…ã‚’å ã‚ã‚‹åŽŸå› ã‚¦ã‚¤ãƒ«ã‚¹ã¨ã—ã¦çŸ¥ã‚‰ã‚Œã¦ã„ã¾ã—ãŸã€‚ 2002å¹´ä¸å›½åºƒæ±çœã«ç«¯
neko2bo 2021/05/30
COVID-19

åŒ»ç™‚

å¿½é‚£è³¢å¿—
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã®æ²»ç™‚è–¬ã€€ãƒ‡ã‚ã‚µãƒ¡ã‚µã‚¾ãƒ³ã€ãƒ¬ãƒ ãƒ‡ã‚·ãƒ“ãƒ«ãªã©ã€€ç¾æ™‚ç‚¹ã§ã®ã‚¨ãƒ“ãƒ‡ãƒ³ã‚¹ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã§ã¯æ²»ç™‚è–¬ã«é–¢ã™ã‚‹ç ”ç©¶ã‚‚é€²ã‚“ã§ã„ã¾ã™ã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã¯åå‰ã®é€šã‚Šæ–°ã—ã„æ„ŸæŸ“ç—‡ã§ã‚ã‚‹ã“ã¨ã‹ã‚‰ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®ãŸã‚ã«é–‹ç™ºã•ã‚ŒãŸæ²»ç™‚è–¬ã¨ã„ã†ã‚‚ã®ã¯ç¾æ™‚ç‚¹ã§ã¯ãªãã€ã“ã‚Œã¾ã§ä»–ã®æ„ŸæŸ“ç—‡ã‚„è† åŽŸç—…ãªã©ã®ç–¾æ‚£ã«ä½¿ã‚ã‚Œã¦ããŸè–¬å‰¤ã‚’æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚‚ä½¿ç”¨ã—ã¦åŠ¹æžœã‚’æ¤œè¨¼ã—ã¦ã„ã‚‹æ®µéšŽã§ã™ã€‚ ã“ã‚Œã¾ã§ã«ã„ãã¤ã‹ã®è–¬å‰¤ãŒåŠ¹æžœãŒè¨¼æ˜Žã•ã‚Œã€ã¾ãŸå¤šãã®è–¬å‰¤ã®æ²»ç™‚åŠ¹æžœãŒç¤ºã•ã‚Œã¾ã›ã‚“ã§ã—ãŸã€‚ ç¾æ™‚ç‚¹ã§ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã®æ²»ç™‚è–¬ã«ã¤ã„ã¦ã¾ã¨ã‚ã¾ã—ãŸã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã®æ²»ç™‚ã®è€ƒãˆæ–¹æ–°åž‹ã‚³ãƒãƒŠã®çµŒéŽã¨æ²»ç™‚è–¬ã®è€ƒãˆæ–¹ï¼ˆdoi:10.1016/j.healun.2020.03.012ã‚’å‚è€ƒã«ç†è€…ä½œæˆï¼‰æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã¯8å‰²ã®äººãŒè»½ç—‡ã§ã‚ã‚Šè‡ªç„¶æ²»ç™’ã—ã¾ã™ã€‚ åŸºæœ¬çš„ã«ã¯ã€æ²»ç™‚è–¬ã¯æ®‹ã‚Š2å‰²ã®ä¸ç‰ç—‡ã€œé‡ç—‡ã®æ–¹ãŒå¯¾è±¡ã¨ã„ã†ã“ã¨ã«ãªã‚Šã¾ã™ã€‚ æ–°åž‹ã‚³ãƒãƒŠã®çµŒéŽã¯ã€ç™ºç—‡ã‹ã‚‰1é€±é–“ç¨‹
neko2bo 2020/07/12
COVID-19

è–¬

å¿½é‚£è³¢å¿—

ã‚ã¨ã§èªã‚€
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã®å¾Œéºç—‡ã«ã¯ã©ã®ã‚ˆã†ãªç—‡çŠ¶ãŒã‚ã‚‹ã®ã‹ï¼Ÿ(å¿½é‚£è³¢å¿—) - å€‹äºº - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
åŽšç”ŸåŠ´åƒçœã‚ˆã‚Šæ–°åž‹ã‚³ãƒãƒŠã«ç½¹æ‚£ã—ãŸæ‚£è€…ã•ã‚“ã®å¾Œéºç—‡ã«ã¤ã„ã¦ã®èª¿æŸ»ã‚’è¡Œã†ã¨ã„ã†ç™ºè¡¨ãŒã‚ã‚Šã¾ã—ãŸã€‚ ã‚³ãƒãƒŠå…ƒæ‚£è€…2åƒäººã®å¾Œéºç—‡èª¿æŸ»ã€€åŽšåŠ´çœã€8æœˆã‹ã‚‰å®Ÿæ–½ æ„ŸæŸ“ç—‡ã®å¾Œéºç—‡ã¨ã¯ã©ã†ã„ã£ãŸç—‡çŠ¶ã‚’æŒ‡ã™ã®ã§ã—ã‚‡ã†ã‹ï¼Ÿ ã¾ãŸã€æ–°åž‹ã‚³ãƒãƒŠã®å¾Œéºç—‡ã¯ã©ã‚Œãã‚‰ã„ã®é »åº¦ã§èµ·ã“ã‚Šã€ã©ã®ã‚ˆã†ãªç—‡çŠ¶ãŒã‚ã‚‹ã®ã§ã—ã‚‡ã†ã‹ï¼Ÿ æ„ŸæŸ“ç—‡ã®å¾Œéºç—‡ã«ã¯ã©ã®ã‚ˆã†ãªã‚‚ã®ãŒã‚ã‚‹ã®ã‹æ„ŸæŸ“ç—‡ã§ã¯ã¨ãã«å¾Œéºç—‡ãŒã¿ã‚‰ã‚Œã‚‹ã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚ æœ‰åãªã¨ã“ã‚ã§ã¯ã€æ—¥æœ¬è„³ç‚Žã‚„ç´°èŒæ€§é«„è†œç‚Žã¨ã„ã†é‡ç—‡æ„ŸæŸ“ç—‡ã§éº»ç—ºãªã©ã®å¾Œéºç—‡ãŒã¿ã‚‰ã‚Œã‚‹ã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚ ã“ã†ã—ãŸé‡ç¯¤ãªå¾Œéºç—‡ä»¥å¤–ã«ã‚‚ã€æ„ŸæŸ“ç—‡ã§ã¯æ§˜ã€…ãªå¾Œéºç—‡ãŒç¾ã‚Œã‚‹ã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚ ä¾‹ãˆã°ã€ã‚¨ãƒœãƒ©å‡ºè¡€ç†±ã¯è‡´æ»çŽ‡ãŒ50ï¼…ã«ã‚‚åŠã¶æã‚ã—ã„æ„ŸæŸ“ç—‡ã§ã™ãŒã€å›žå¾©ã—ãŸå¾Œã«ã‚‚å€¦æ€ æ„Ÿã‚„é–¢ç¯€ç—›ã€é ç—›ã€è„±æ¯›ã€é£Ÿæ¬²ä½Žä¸‹ãªã©ã®æ…¢æ€§ç—‡çŠ¶ãŒç¶šãã“ã¨ãŒçŸ¥ã‚‰ã‚Œã¦ãŠã‚Šã€Œpost-ebola syndromeï¼ˆã‚¨ãƒœãƒ©å¾Œç—‡å€™ç¾¤ï¼‰ã€ã¨å‘¼ã°ã‚Œã¦ã„ã¾ã™ã€‚ ã‚¨
neko2bo 2020/07/12
COVID-19

å¿½é‚£è³¢å¿—
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã«é›†å›£å…ç–«ã¯æœŸå¾…ã§ããªã„ï¼Ÿã€€ç½¹æ‚£å¾Œæ•°ãƒ¶æœˆã§æŠ—ä½“ãŒé™°æ€§ã«ãªã‚‹ã¨ã„ã†å ±å‘Šã‚’ã©ã†è§£é‡ˆã™ã¹ãã‹ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
ä»Šã‚„æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã®æ„ŸæŸ“è€…ã¯870ä¸‡äººã«é”ã—ã¦ãŠã‚Šã€ã“ã®ã†ã¡46ä¸‡äººï¼ˆ5.3%ï¼‰ã®æ–¹ãŒäº¡ããªã‚‰ã‚Œã¦ã„ã¾ã™ã€‚ ã¤ã¾ã‚Š9å‰²ä»¥ä¸Šã®æ–¹ã¯æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã‹ã‚‰å›žå¾©ã—ã¦ã„ã‚‹ã“ã¨ã«ãªã‚Šã¾ã™ã€‚ ä¸€èˆ¬çš„ã«ã€æ„ŸæŸ“ç—‡ã«ç½¹æ‚£ã—å›žå¾©ã—ãŸäººã¯ä¸€å®šã®æœŸé–“ã¯æ„ŸæŸ“ã—ãªããªã‚‹ã“ã¨ãŒå¤šãã€ä¾‹ãˆã°éº»ã—ã‚“ï¼ˆã¯ã—ã‹ï¼‰ã«ã¯ä¸€åº¦ç½¹ã‚‹ã¨ç”Ÿæ¶¯æ„ŸæŸ“ã—ãªã„ã“ã¨ãŒå¤šã„ã¨ã•ã‚Œã¾ã™ã€‚ ä¸€æ–¹ã€æ€§æ„ŸæŸ“ç—‡ã§ã‚ã‚‹æ¢…æ¯’ã¯ä¸€åº¦æ„ŸæŸ“ã—ã¦ã‚‚ä½•åº¦ã§ã‚‚æ„ŸæŸ“ã™ã‚‹æ„ŸæŸ“ç—‡ã§ã™ã€‚ æ–°åž‹ã‚³ãƒãƒŠã«ã¤ã„ã¦ã¯æ„ŸæŸ“è€…ã«å…ç–«ãŒã§ãã‚‹ã®ã‹ã€ã§ãã‚‹ã¨ã—ãŸã‚‰ã©ã‚Œãã‚‰ã„æŒç¶šã™ã‚‹ã®ã‹ã«é–¢å¿ƒãŒå¯„ã›ã‚‰ã‚Œã¦ã„ã¾ã—ãŸãŒã€å…ˆæ—¥ä¸å›½ã‹ã‚‰æŠ—ä½“ã¯é•·æœŸé–“æŒç¶šã—ãªã„å¯èƒ½æ€§ãŒã‚ã‚‹ã¨ã„ã†å ±å‘ŠãŒç™ºè¡¨ã•ã‚Œã¾ã—ãŸã€‚ é›†å›£å…ç–«ã¨ã¯ã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³ã¯é›†å›£å…ç–«ã‚’ç²å¾—ã™ã‚‹ã“ã¨ã§æµè¡Œã‚’å°ã˜è¾¼ã‚ã‚‹æ–¹é‡ã‚’å–ã£ã¦ã„ã¾ã™ã€‚ ã“ã‚Œã¯æ”¿åºœã«ã‚ˆã‚‹ãƒãƒƒã‚¯ãƒ€ã‚¦ãƒ³ãªã©ã®å¼·åŠ›ãªä»‹å…¥ã¯è¡Œã‚ãšã€æ–°åž‹ã‚³ãƒãƒŠã«å¯¾ã™ã‚‹å…ç–«ã‚’æŒã¤äººã‚’å¢—ã‚„ã™ã“ã¨ã§é›†å›£å…ç–«ã‚’æ—©
neko2bo 2020/06/22
COVID-19

å¿½é‚£è³¢å¿—

å…ç–«
ãƒªãƒ³ã‚¯
ã€ŒPCRæ¤œæŸ»ãªã—ã§é€€é™¢å¯èƒ½ã€ã¨ã—ã¦ã‚‚æœ¬å½“ã«å®‰å…¨ã‹ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
ï¼•æœˆï¼’ï¼™æ—¥ã€åŠ è—¤ åŽšç”ŸåŠ´åƒå¤§è‡£ã‚ˆã‚Šæ–°åž‹ã‚³ãƒãƒŠæ‚£è€…ãŒPCRæ¤œæŸ»ãªã—ã§ã‚‚é€€é™¢ã§ãã‚‹æ–°ãŸãªåŸºæº–ã‚’ç¤ºã—ã¾ã—ãŸã€‚ æ–°ãŸãªåŸºæº–ã§ã¯åŽŸå‰‡ã€ç™ºç—‡ã‹ã‚‰ï¼‘ï¼”æ—¥é–“ãŒçµŒéŽã—ã€ã‹ã¤ç—‡çŠ¶ãŒè»½å¿«ã—ã¦ã‹ã‚‰ï¼—ï¼’æ™‚é–“çµŒéŽã™ã‚Œã°ã€ï¼°ï¼£ï¼²æ¤œæŸ»ãªã—ã§é€€é™¢ã§ãã‚‹ã€‚è‡ªå®…ãƒ»å®¿æ³Šç™‚é¤Šã®è§£é™¤åŸºæº–ã«ã¤ã„ã¦ã‚‚ã“ã‚Œã«æº–ã˜ã‚‹ã€‚ç™ºç—‡ã‹ã‚‰ï¼‘ï¼æ—¥ãŸãŸãšã«ç—‡çŠ¶ãŒè»½å¿«ã—ãŸå ´åˆã¯å¾“æ¥é€šã‚Šã€ï¼’å›žç¶šã‘ã¦æ¤œæŸ»ã§é™°æ€§ç¢ºèªã§ãã‚Œã°é€€é™¢å¯èƒ½ã¨ã—ãŸã€‚ å‡ºå…¸:ï¼°ï¼£ï¼²æ¤œæŸ»ãªã—ã§ã‚‚é€€é™¢å¯èƒ½ã«ã€€åŽšåŠ´ç›¸ãŒæ–°ãŸãªé€€é™¢åŸºæº– ã“ã‚Œã¾ã§ã®é€€é™¢åŸºæº–ï¼ˆåŽšç”ŸåŠ´åƒçœæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡å¯¾ç–æŽ¨é€²æœ¬éƒ¨ äº‹å‹™é€£çµ¡ ä»¤å’Œï¼’å¹´ï¼”æœˆï¼’æ—¥ï¼‰ã“ã‚Œã¾ã§ã®åŸºæº–ã§ã¯ç—‡çŠ¶ãŒè»½å¿«ã—ã¦ã‹ã‚‰24æ™‚é–“ãŒçµŒéŽã—ã¦ã‹ã‚‰ã€2å›žã®PCRæ¤œæŸ»ã®é™°æ€§ã‚’ç¢ºèªã—ã¦ã‹ã‚‰ã§ãªã„ã¨é€€é™¢ã§ãã¾ã›ã‚“ã§ã—ãŸã€‚ ãã‚ŒãŒã€ç™ºç—‡ã‹ã‚‰14æ—¥çµŒã£ã¦ç—‡çŠ¶ãŒè»½å¿«ã—ã¦ã„ã‚Œã°PCRæ¤œæŸ»ã‚’ã›ãšã«é€€é™¢å¯èƒ½ã¨ãªã£ãŸã‚ã‘ã§ã™ã€‚ ã€ŒPCRæ¤œæŸ»ã‚’ã›ãšã«é€€é™¢ã—ã¦æœ¬å½“ã«å¤§ä¸ˆå¤«ãªã®ã‹ã€ ã€Œ
neko2bo 2020/05/31
ç´ æœ´ãªç–‘å•ã¨ã—ã¦ã€‚ã“ã†ã„ã†åˆ†ã‹ã‚Šã‚„ã™ã„è§£èª¬ã‚’ã€ä½•æ•…ã€å…¬çš„æ©Ÿé–¢ãŒã‚„ã‚‰ãªã„ã‚“ã ã‚ã†ã‹ã—ã‚‰ï¼Ÿï¼Ÿã£ã¦ã€‚

å¿½é‚£è³¢å¿—

COVID-19
ãƒªãƒ³ã‚¯
ç·Šæ€¥äº‹æ…‹å®£è¨€ã‹ã‚‰3é€±é–“ã€€æµè¡ŒçŠ¶æ³ã¯ã©ã†å¤‰ã‚ã£ãŸã‹ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
4æœˆ7æ—¥ã«ç·Šæ€¥äº‹æ…‹å®£è¨€ãŒå‡ºã•ã‚Œã¦3é€±é–“ãŒçµŒã¡ã¾ã—ãŸã€‚ ç†è€…ã¯ç·Šæ€¥äº‹æ…‹å®£è¨€ã®ç™ºä»¤å¾Œã«ä»¥ä¸‹ã®è¨˜äº‹ã‚’æŠ•ç¨¿ã—ã¾ã—ãŸã€‚ ç·Šæ€¥äº‹æ…‹å®£è¨€ã€€ç§ãŸã¡ã«ã§ãã‚‹ã“ã¨ ã“ã“ã§ã¯æ‚£è€…ã®æ€¥å¢—ã€åŒ»ç™‚å´©å£Šã®é€²è¡Œã€ãã—ã¦æˆ‘ã€…ãŒã“ã‚Œã‹ã‚‰è¡Œã†ã¹ãã€Œãƒãƒ³ãƒžãƒ¼ï¼†ãƒ€ãƒ³ã‚¹ã€ã®æ¦‚å¿µã«ã¤ã„ã¦ã”ç´¹ä»‹ã—ã¾ã—ãŸã€‚ ç·Šæ€¥äº‹æ…‹å®£è¨€ã®ç™ºä»¤ã‹ã‚‰3é€±é–“ã§æ–°è¦ã®å ±å‘Šæ•°ã¯æ¸›ã£ã¦ã„ã¾ã™ãŒã€æœ¬å½“ã«æ„ŸæŸ“è€…ã¯æ¸›ã£ã¦ã„ã‚‹ã¨è¨€ãˆã‚‹ã®ã§ã—ã‚‡ã†ã‹ã€‚ ãã—ã¦ä»Šå¾Œç§ãŸã¡ãŒãªã™ã¹ãã“ã¨ã¯ä½•ã§ã—ã‚‡ã†ã‹ã€‚ æ‚£è€…ç™ºç”Ÿæ•°ã¯æ˜Žã‚‰ã‹ã«æ¸›å°‘ã«è»¢ã˜ã¦ã„ã‚‹ç·Šæ€¥äº‹æ…‹å®£è¨€ã‹ã‚‰2é€±é–“ã‚’çµŒéŽã—ãŸé ƒã‹ã‚‰æ˜Žã‚‰ã‹ã«æ–°è¦æ‚£è€…æ•°ãŒæ¸›å°‘ã—ã¦ã„ã¾ã™ã€‚ æ±äº¬éƒ½ã®æ–°åž‹ã‚³ãƒãƒŠæ‚£è€…ç™ºç”Ÿæ•°ã®æŽ¨ç§»ï¼ˆæ±äº¬éƒ½ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ å¯¾ç–ã‚µã‚¤ãƒˆã‚ˆã‚Šï¼‰æ—¥æœ¬å…¨å›½ã®æ–°åž‹ã‚³ãƒãƒŠæ‚£è€…ç™ºç”Ÿæ•°ã®æŽ¨ç§»ï¼ˆéƒ½é“åºœçœŒåˆ¥æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“è€…æ•°ãƒžãƒƒãƒ— ã‚¸ãƒ£ãƒƒã‚°ã‚¸ãƒ£ãƒ‘ãƒ³æ ªå¼ä¼šç¤¾ã‚ˆã‚Šï¼‰æ±äº¬éƒ½ã‚‚1æ—¥ã®æ–°è¦ç™ºç—‡è€…æ•°ãŒ100äººã‚’åˆ‡ã‚‹æ—¥ãŒå‡ºã¦ãã‚‹ãªã©ã€ç·Šæ€¥äº‹æ…‹å®£è¨€ã®
neko2bo 2020/04/30
COVID-19

åŒ»ç™‚

å¿½é‚£è³¢å¿—
ãƒªãƒ³ã‚¯
å€‹äººã§ã®PCRæ¤œæŸ»ã‚ãƒƒãƒˆã®ä½¿ç”¨ã¯æŽ§ãˆã¾ã—ã‚‡ã†ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
æ¥½å¤©ã‚ˆã‚ŠPCRæ¤œæŸ»ã‚ãƒƒãƒˆãŒè²©å£²é–‹å§‹ã¨ãªã‚Šã¾ã—ãŸã€‚ ã“ã®ã‚ãƒƒãƒˆã‚’ç”¨ã„ã‚‹ã“ã¨ã§ã€ç—…é™¢ã‚’å—è¨ºã™ã‚‹ã“ã¨ãªãPCRæ¤œæŸ»ãŒæ–½è¡Œå¯èƒ½ã¨ã®ã“ã¨ã§ã™ã€‚ ã—ã‹ã—ã€PCRæ¤œæŸ»ã¯åŒ»ç™‚å¾“äº‹è€…ã«ã‚ˆã£ã¦æ£ã—ã„æ–¹æ³•ã§æ¤œä½“ã‚’æŽ¡å–ã—ã€æ£ã—ãçµæžœã‚’è§£é‡ˆã›ãã°ãªã‚Šã¾ã›ã‚“ã€‚ ç†è€…ã¯æ„ŸæŸ“ç—‡å°‚é–€åŒ»ã§ã™ãŒã€ä¸€èˆ¬ã®æ–¹ãŒã“ã®PCRæ¤œæŸ»ã‚ãƒƒãƒˆã‚’ä½¿ç”¨ã™ã‚‹ã“ã¨ã¯æŽ¨å¥¨ã—ã¾ã›ã‚“ã€‚ æ¥½å¤©ã‹ã‚‰è²©å£²ã•ã‚Œã¦ã„ã‚‹PCRæ¤œæŸ»ã‚ãƒƒãƒˆã¨ã¯4æœˆ20æ—¥ã‚ˆã‚Šæ¥½å¤©ã§PCRæ¤œæŸ»ã‚ãƒƒãƒˆãŒè²©å£²é–‹å§‹ã«ãªã£ã¦ã„ã¾ã™ã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹PCRæ¤œæŸ»ã‚ãƒƒãƒˆ COVID-19 PCR ã€Œæœ¬æ¤œæŸ»ã‚ãƒƒãƒˆã¯ã€ã‚¸ã‚§ãƒã‚·ã‚¹ãƒ˜ãƒ«ã‚¹ã‚±ã‚¢æ ªå¼ä¼šç¤¾ãŒé–‹ç™ºã—ã€æ¥½å¤©æ ªå¼ä¼šç¤¾ãŒæ³•äººçª“å£ã¨ãªã‚Šã‚µãƒ¼ãƒ“ã‚¹ã‚’æä¾›ã—ã¦ã„ã¾ã™ã€‚ã€ã¨ã®ã“ã¨ã§ã™ã€‚ 4æœˆ21æ—¥21æ™‚æ™‚ç‚¹ã§ãƒ›ãƒ¼ãƒ ãƒšãƒ¼ã‚¸ã«ã¯ã€Œç¾åœ¨ã€å¤§å¤‰å¤šãã®ãŠç”³è¾¼ã¿ã‚’ã„ãŸã ã„ã¦ãŠã‚Šã€é †æ¬¡ã”å¯¾å¿œã‚’ã•ã›ã¦ã„ãŸã ã„ã¦ãŠã‚Šã¾ã™ã€‚ã”å›žç”ã«ãŠæ™‚é–“ãŒã‹ã‹ã‚‹å ´åˆãŒã”ã–ã„ã¾ã™ãŒã€ä½•å’ã”å®¹èµ¦ã„ãŸã ãã¾
neko2bo 2020/04/22
COVID-19

å¿½é‚£è³¢å¿—

PCRã‚ãƒƒãƒˆ

æ¥½å¤©
ãƒªãƒ³ã‚¯
1